Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aim Immunotech Inc
(NY:
AIM
)
0.2440
-0.0006 (-0.25%)
Official Closing Price
Updated: 4:10 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aim Immunotech Inc
< Previous
1
2
3
4
5
Next >
Exploring AIM ImmunoTech's Earnings Expectations
November 07, 2024
Via
Benzinga
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
November 04, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024
August 15, 2024
AIM stock results show that AIM ImmunoTech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024
May 16, 2024
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Preview: AIM ImmunoTech's Earnings
April 01, 2024
Via
Benzinga
Preview: AIM ImmunoTech's Earnings
November 14, 2023
Via
Benzinga
Earnings Outlook For AIM ImmunoTech
August 14, 2023
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
April 02, 2024
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For April 2, 2024
April 02, 2024
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.
Via
Benzinga
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
March 25, 2024
The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
February 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 11, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 09, 2024
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
Via
InvestorPlace
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
January 05, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
December 29, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Provides Update Regarding Annual Meeting
November 28, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying
November 28, 2023
The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
November 06, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
October 02, 2023
The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today?
September 11, 2023
AIM ImmunoTech Inc (NYSE: AIM) announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen (rintatolimod) as a component of...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 05, 2023
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
August 23, 2023
Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
Via
Benzinga
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
August 23, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
Via
Benzinga
Earnings Scheduled For August 11, 2023
August 11, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.